(Date:3/17/2010)... BALTIMORE , March 17 Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a ... the value of oncology drugs, today announced its financial results for the third fiscal quarter ... the Company,s Form 10-Q at www.championsbiotechnology.com . , ... ...
(Date:3/17/2010)... ( AEZS, TSX: AEZ) (the "Company"), a late-stage drug development company specialized in ... and operating results before market open on Wednesday, March 24, 2010 . ... later that same day at 10:00 a.m., Eastern Time . , ... ...
(Date:3/17/2010)... ... on Stereomicroscopy and Converting to 3D Imaging , ... Thornwood, N.Y. (PRWEB) March 17, 2010 -- Carl Zeiss, ... and industrial applications, recently announced two exciting online promotions. For a limited time, and ...
(Date:3/16/2010)... 16, 2010)Pancreatic cancerknown as the most fatal cancer with ... promising approach may come in the form of tiny ... a novel procedure called "nanoembolization," said researchers at the ... Tampa, Fla. , "As current treatments for pancreatic cancer ...
Breaking Biology Technology:Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 5Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 6Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 7Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 8Æterna Zentaris to Announce Fourth Quarter Full Year 2009 Financial and Operating Results on March 24, 2010 2Carl Zeiss Offers Online Promotions 2Going for gold with a novel interventional radiology treatment for pancreatic cancer 2Going for gold with a novel interventional radiology treatment for pancreatic cancer 3